NAHC 2026 KEYNOTE SPEAKERS


March 25, 2026
Scott Gottlieb, MD

Former Commissioner of the US Food and Drug Administration 
Senior Fellow at the American Enterprise Institute for Public Policy Research
Partner, New Enterprise Associates

Scott Gottlieb, MD, is a physician and served as the 23rd Commissioner of the US Food and Drug Administration from 2017 to 2019. He is currently a senior fellow at the American Enterprise Institute for Public Policy Research and a partner at the venture capital firm New Enterprise Associates. 

Previously, Dr. Gottlieb served as the FDA’s Deputy Commissioner for Medical and Scientific Affairs and, before that, as a Senior Adviser to the Administrator of the Centers for Medicare and Medicaid Services, where he supported policy work on quality improvement and the agency’s coverage process, particularly as it related to new medical technologies. He is a regular contributor to CNBC and CBS News’ Face the Nation. He serves on the board of directors of Pfizer, Inc., Illumina, Inc., and TempusAI. 

Dr. Gottlieb is an elected member of the National Academy of Medicine and completed medical school and a residency in internal medicine at the Mount Sinai School of Medicine in New York, where he currently serves on the executive committee of the Mount Sinai Health System’s board of directors and co-chairs the board’s education committee. He graduated from Wesleyan University, where he majored in economics, and currently serves on the University’s board of directors. 

 


March 26, 2026
Katrina Armstrong, MD

Executive Vice President for Health and Biomedical Sciences 
Dean of the Faculties of Health Sciences and the Vagelos College of Physicians and Surgeons 
Chief Executive Officer of Columbia University Irving Medical Center 
Harold and Margaret Hatch Professor in the Faculty of Medicine 

Katrina Armstrong, MD, leads Columbia University’s medical campus, serving since 2022 as the Chief Executive Officer of Columbia University Irving Medical Center (CUIMC), which includes the Vagelos College of Physicians and Surgeons (VP&S), the School of Nursing, the College of Dental Medicine, and the Mailman School of Public Health. She is Executive Vice President for Health and Biomedical Sciences for Columbia University, Dean of the Faculties of Health Sciences and the Vagelos College of Physicians and Surgeons, and the Harold and Margaret Hatch Professor in the Faculty of Medicine. She previously served as Interim President of Columbia University in the City of New York.

Dr. Armstrong is an internationally recognized investigator in medical decision making, quality of care, and cancer prevention and outcomes, an award-winning teacher, and a primary care physician. She has served on multiple advisory panels for academic and federal organizations and has been elected to the National Academy of Medicine, the American Academy of Arts and Sciences, the Association of American Physicians, and the American Society for Clinical Investigation. Before joining Columbia, Dr. Armstrong was the Jackson Professor of Clinical Medicine at Harvard Medical School, Chair of the Department of Medicine and Physician-in-Chief of Massachusetts General Hospital, and Professor of Epidemiology at the Harvard T.H. Chan School of Public Health. Before joining Harvard, she was Chief of the Division of General Internal Medicine, Associate Director of the Abramson Cancer Center, and Co-Director of the Robert Wood Johnson Clinical Scholars Program at the University of Pennsylvania. She is a graduate of Yale University (BA degree in architecture), Johns Hopkins (MD degree), and the University of Pennsylvania (MS degree in clinical epidemiology). She completed her residency training in internal medicine at Johns Hopkins. 

 

Program